. 2022 Mar 29;61:103785. doi: 10.1016/j.msard.2022.103785

Table 3.

Quantitative Analysis of Spike Antibody levels in Select Populations.

	Spike Antibody level (index value)	Statistic	p-value
B-Cell Therapy (n=27)	2.67 ± 3.80	t=-4.7011	<0.001
No B-Cell Therapy (n=23)	7.78 ± 4.09	t=-4.7011	<0.001

S1P Modulators (n=4)	5.54 ± 5.17	t=0.2611	0.795
No S1P Modulators (n=46)	4.91 ± 4.54	t=0.2611	0.795

Undetectable CD19 cells (<1%) at vaccination (n=22)	1.66 ± 2.85	t=4.51203	<0.001
Detectable CD19 cells (≥1%) at vaccination (n=10)	7.16 ± 3.88	t=4.51203	<0.001

Hypogammaglobulinemia (IgG < 600 mg/dL) (n=5)	0.68 ± 0.31	t=-1.75538	0.045
No Hypogammaglobulinemia (IgG ≥ 600 mg/dL) (n=28)	4.12 ± 4.32	t=-1.75538	0.045

Lymphopenia (<1 × 10⁹/L) (n=11)	4.49 ± 4.78	t=-0.36298	0.359
No Lymphopenia (≥1 × 10⁹/L) (n=39)	5.08 ± 4.53	t=-0.36298	0.359